Healthcare Services & Insurance
Healthcare delivery services, insurance coverage, and managed care organizations.
9 events touching this theme
- MEDIUM CONFIDENCEMAINSTREAM ONLY1 DAY AGOHIV PREVENTION & ACCESS
HIV prevention drug hailed as breakthrough, but who gets access?
HIV prevention drug advances as breakthrough, raising questions about equitable global access and distribution.
MAINSTREAMSourced from Al Jazeera
- MEDIUM CONFIDENCEMAINSTREAM ONLY2 DAYS AGOUS DISEASE OUTBREAKS
Pennsylvania confirms fifth measles-associated death as US outbreak grows
Pennsylvania reports fifth measles death as US outbreak expands, raising public health and healthcare system strain.
MAINSTREAMSourced from Al Jazeera
- MEDIUM CONFIDENCEMAINSTREAM ONLY2 DAYS AGOGLP-1 DRUG DEVELOPMENT
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Eli Lilly's combination obesity treatment shows improved weight loss results in mid-stage trial.
MAINSTREAMSourced from CNBC
- MEDIUM CONFIDENCEMAINSTREAM ONLY2 DAYS AGOHIV PREVENTION & ACCESS
It’s the ‘closest thing to an HIV vaccine’, but who gets access?
New HIV vaccine candidate shows promise; access and distribution questions emerge.
MAINSTREAMSourced from Al Jazeera
- MEDIUM CONFIDENCEMAINSTREAM ONLY3 DAYS AGOGLP-1 DRUG MARKET
People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study
Novo Nordisk's Wegovy oral formulation maintains weight-loss efficacy in real-world patients switching from injectable GLP-1 drugs.
MAINSTREAMSourced from CNBC
SPONSORED
- MEDIUM CONFIDENCEMAINSTREAM ONLY3 DAYS AGOCOUNTERFEIT DRUG SMUGGLING
Two Indian nationals charged with smuggling counterfeit Ozempic from China: DOJ
DOJ charges two Indian nationals with smuggling counterfeit Ozempic from China into the U.S.
MAINSTREAMSourced from CNBC
- MEDIUM CONFIDENCEMAINSTREAM ONLY4 DAYS AGOPHARMA LICENSING & PARTNERSHIPS
Novo Nordisk strikes second licensing deal since frosty capital-markets day
Novo Nordisk signs second licensing deal following recent investor relations setback.
MAINSTREAMSourced from MarketWatch
- MEDIUM CONFIDENCEMAINSTREAM ONLY4 DAYS AGOGLP-1 DRUG SAFETY
Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
Ozempic users should get routine eye exams to assess vision loss risk, per MarketWatch health guidance.
MAINSTREAMSourced from MarketWatch
- MEDIUM CONFIDENCEMAINSTREAM ONLY5 DAYS AGOLONGEVITY & ANTI-AGING BIOTECH
The longevity boom is getting ahead of the science
Longevity science claims are outpacing evidence, raising questions about biotech and healthcare investment validity.
MAINSTREAMSourced from Al Jazeera